Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams Clinical Resources
Below are up-to-date resources for clinicians and clinical administrators on the role of the pharmacist in preventing, treating, and recovering from substance use disorders.
Advancing the Pharmacist’s Role
Clinical Pharmacist Care Manager Model (ASHP)
Overview of a clinical pharmacist care manager (CPCM) model for medications for OUD treatment.
Opioid Use Disorders: Interventions for Community Pharmacists (CPNP)
Toolkit for OUD intervention strategies and best practices.
Pharmacist Verification of Buprenorphine Providers (SAMHSA)
Tools and guidance for pharmacists to verify practitioner waivers to prescribe or dispense buprenorphine.
Role of the CPS in Medication Assisted Treatment for Opioid Use Disorder (Indian Country ECHO)
Handout about the role of clinical pharmacy specialists as integral providers in the provision of comprehensive medication management services for patients with opioid use disorder.
Leveraging the Role of Community Pharmacists in the Prevention, Surveillance, and Treatment of Opioid Use Disorders (ASCP Journal)
Literature review exploring novel programs designed to capitalize on the role of the community pharmacist in helping to reduce opioid-related harms, as well as an evaluation of existing practices already in place.
Prescription Drug Monitoring Programs (PDMPs)
Prescription Drug Monitoring Programs: What Providers Need to Know (CDC)
Overview resource of PDMP for providers.
PDMP Assist (BJA)
Comprehensive array of services, support, resources, and strategies to PDMPs, federal partners and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse, abuse and diversion of prescription drugs.
Treatment Improvement Protocol #59 – Improving Cultural Competence (SAMHSA)
Best practices for developing culturally responsive behavioral health services.
TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment (SAMHSA)
Tips for SUD treatment providers to increase participation and retention in SUD treatment.
Provider Care Coordination Agreement – Pain Clinical Pharmacy Specialist – Template (VA)
Customizable template created by the PBM Clinical Pharmacy Practice Office with standard components that foster clinical pharmacy practice standardization.
Opioid Guideline Mobile App (CDC)
The app includes a Morphine Milligram Equivalent (MME) calculator, summaries of key recommendations, and an interactive motivational interviewing feature to help providers practice effective communications skills and prescribe with confidence.
Pharmacy Toolkit (AAOA)
Toolkit to help pharmacists engage in conversations with their patients and healthcare provider colleagues about prescription opioids.
Pharmacist Toolkit: Opioid Use Disorder (CPNP)
Toolkit for the screening and medication management of OUD.
Pharmacists Guide to Harm Reduction Strategies for People Who Inject Drugs (CPNP)
Toolkit for harm reduction strategies and best practices.
Guide for the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics (HHS)
Provides advice to clinicians who are contemplating or initiating a reduction in opioid dosage or discontinuation of long-term opioid therapy for chronic pain.
Calculating Total Daily Dose of Opioids for Safer Dosage (CDC)
Guide for calculating total daily dose of opioids and application.
Pharmacist Toolkit: Benzodiazepine Taper (CPNP)
Toolkit for benzodiazepine taper strategies and best practices.
Medication for the Treatment of Alcohol Use Disorder: A Brief Guide (SAMHSA)
Best practices for AUD screening, treatment planning, medication options, and monitoring.
Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants (SAMHSA)
Comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants.
Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use (HHS)
Guidance for providers when changing a patient’s chronic pain therapy.
Treatment of Stimulant Use Disorders (SAMHSA)
Guide that discusses effective practices to treat stimulant use disorders, clinical challenges associated with these disorders, and implementation strategies that can be used to address those challenges.
Overdose Death Rates Monitoring (NIDA)
Current trends and statistics related to overdose death rates.
Medications for Addiction Treatment (MAT)
TIP 63: Medications for Opioid Use Disorder (SAMHSA)
This Treatment Improvement Protocol (TIP) reviews the use of the three medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Business Plan for Medication-Assisted Treatment (PCSS)
Medications that treat opioid use disorder are safe, effective, and can be prescribed and/or administered at community health centers, with a sustainable business plan.
Ensuring MAT Benefits the Individual & the Community (didgʷálič)
Ever wondered how to offer medication-assisted treatment safely? Learn how the didgʷálič Wellness Center – owned and operated by the Swinomish Indian Tribal Community – ensures that the medications they offer are beneficial.
Statutes, Regulations, and Guidelines (SAMHSA)
Learn about the federal statutes, regulations, and guidelines that apply to opioid treatment programs and medication-assisted treatment.
Tribal MAT Policies and Procedures Template (NPAIHB)
Adapted from tribal medication-assisted treatment policies and procedures by the Northwest Portland Area Indian Health Board.
Clinical Opiate Withdrawal Scale (COWS)
11-item scale designed to be administered by a clinician to rate common signs and symptoms of opiate withdrawal; objective and subjective in nature.
Objective Opioid Withdrawal Scale (OOWS)
Scale for measuring opioid withdrawal that relies on clinical observation; useful in measuring objectively measurable symptoms of opioid withdrawal.
The Subjective Opioid Withdrawal Scale (SOWS)
Scale for measuring opioid withdrawal that records the patient’s rating of withdrawal on a 16-item scale.
Overdose Prevention and Naloxone Training – Outline (Indian Country ECHO)
Sample outline for an overdose prevention and naloxone training; provided by a tribal partner in the Pacific Northwest.
The Overdose Safety Plan: A Quick Guide for Clinicians (ODSP)
Step-by-step instructions for developing an overdose safety plan.
Opioid Overdose Prevention Toolkit (SAMHSA)
Toolkit offering strategies to health care providers, communities, and local governments for developing practices and policies to help prevent opioid-related overdoses and deaths.
An Indigenous Perspective on Overdose Prevention & Harm Reduction (FNHA)
First Nations Health Authority recommendations on the adoption of harm reduction practices.
Tribal Naloxone Policy
Sample naloxone policy shared by a tribe located in Washington state.
Naloxone Overview (IHS)
Information and training videos about this prescription medication that can temporarily reverse opioid overdose and can save lives.
Pharmacist Naloxone Prescription Reporting Form (IHS)
Sample naloxone prescription reporting from the IHS
Naloxone Access: A Practical Guide for Pharmacists (CPNP)
A naloxone informational handout.
Medicaid Reimbursement for Take-home Naloxone (PTP)
Toolkit discussing naloxone, Medicaid, and Medicaid drug coverage policies.
Naloxone Resources (PTP)
Naloxone product comparisons, and prescription and dispensing instructions.
Guide for Pharmacists Dispensing Naloxone to Patients (PTP)
Easy to use instructions for dispensing naloxone.
Pharmacy-Lead SUD Community Resources
Substance use disorder resources for American Indian and Alaskan Native community members.
Words Matter When We Talk About Addiction (NPAIHB)
Fact sheet for AI/AN community members on the importance of using non-stigmatizing, supportive language when talking about substance use disorders.
A Trickster Tale – Outsmarting Opioids through Education and Action (NPAIHB)
A booklet for tribal community members on preventing, treating, and recovering from opioid use disorder.
Text Message Campaign Card (NPAIHB)
Postcard, perfect for clinic settings, to encourage your patients to text ‘opioids’ to 97779 to learn more about opioid misuse prevention, treatment, and recovery.
What People with Opioid Addiction Want You to Know (NPAIHB)
Words of wisdom from tribal community members about what you should know about opioids.
Recovering from Opioid Addiction is Possible (NPAIHB)
We can heal from opioid use disorder. See how others have walked the road to recovery.
Supporting Someone with Opioid Addiction (NPAIHB)
Support can be lifesaving. Hear the stories of tribal community members who have helped their friends and relatives through tough times.
Medication-Assisted Treatment Myths (NPAIHB)
MAT helps many people with opioid use disorder recover. It is more than twice as effective as counseling alone. Learn the facts here.
Rx Pain Medications, Know the Options, Get the Facts (SAMHSA)
Fact sheet with focus on alternative pain management methods such as acupuncture, cognitive behavioral therapy, and meditation.
Words Matter: When Providers Talk About Addiction (NPAIHB)
Fact sheet for clinicians on using non-stigmatizing language when talking about substance use disorders.
A Culture of Respect: Providing Clients with Compassionate Care (didgʷálič)
Learn about how the didgʷálič Wellness Center incorporates harm reduction into their successful approach for treating individuals with opioid use disorder.
Language of Addiction (Indian Country ECHO)
Presentation slides related to the importance of using non-stigmatizing language and appropriate terminology related to substance use.
Substance Use Disorder Clinical Pharmacy Boot Camp 2020 (VA)
Online, self-paced clinical training program related to SUD.
Using the Prescription Drug Monitoring Program to Promote Patient Safety in Opioid Prescribing and Dispensing (CDC)
Online training module related to PDMP use while prescribing and dispensing opioids.
Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals (ATTC)
Training designed to provide a broad overview of buprenorphine, its effects, and the role of non-physician practitioners in providing and supporting the treatment of individuals receiving this medication.
Prescription Opioid Addiction Treatment Study: Training Materials (ATTC)
Package of tools and training resources for substance use disorders treatment providers.
Practitioner Training (SAMHSA)
SAMHSA’s practitioner training resource that offers tools, training, and technical assistance to practitioners in the fields of mental health and substance use disorders.
Steps to Obtain your MAT Waiver (PCSS)
Guidance for obtaining waiver (required by the DEA) for the use of buprenorphine in medication-assisted treatment.
Technical Assistance and Capacity Building
Technical Assistance and Capacity Building (Indian Country ECHO)
Free service designed to optimize IHS, tribal, and urban clinic policies, enhance care delivery for patients, and build community capacity to prevent and treat complex medical conditions, including substance use disorders.
Substance Use Warmline
Free confidential service that provides on-demand clinical recommendations from experts on effectively treating patients with substance use disorders; designed for providers practicing at IHS, tribal, and urban facilities.
Sample Policy and Procedure (P&P)
Sample primary care office based opioid treatment P&P.
An international, multidisciplinary resource for professionals in the addictions treatment and recovery services field.
Tribes Leading the Way
Tribal Opioid Response: National Strategic Agenda (NPAIHB)
Strategic agenda designed to comprehensively address the tribal opioid epidemic.
California Consortium for Urban Indian Health: MAT Project (CCUIH)
Project designed to meet the specific prevention, treatment, and recovery needs of California’s Urban Indian communities.
First Nations Health Authority Indigenous Harm Reduction Principles and Practices
Indigenous Harm Reduction is a process of integrating cultural knowledge and values into the strategies and services associated with the work of harm reduction.
didgʷálič Wellness Center (video)
In one year, didgʷálič Wellness Center- owned and operated by the Swinomish Indian Tribal Community – cut tribal opioid overdose deaths in half. Learn about their unique treatment model from the perspective of staff and clients.
White Earth Nation – No More (video)
Watch how a determined effort by the White Earth Nation is making a positive change in our community and a difference in the lives of at risk youth.
Penobscot Nation Using Traditional Culture to Fight Addiction (video)
Recognizing that issues with substance abuse in native communities often arise from intergenerational trauma, the Penobscot Nation attempts to reacquaint criminal drug offenders with tribal traditions and cultural practices to help them make a full recovery.
Telehealth and Privacy: Tips and Guidance for SUD and Mental Health Treatment Providers (CeE-PHI)
Guidance for providers to help maintain patient privacy while providing telehealth services.
Top Seven Telehealth Privacy Considerations for SUD Treatment and Recovery Support Providers (CoE-PHI)
8-Part podcast series focusing on tips and resources for SUD and recovery support treatment providers on the topic of maintaining patient privacy while providing telehealth services.
Understanding the New Changes to 42 CFR Part 2 (CoE-PHI)
Webinar to help providers understand the changes to 42 CFR Part 2 and SAMHSA guidance regarding patient privacy.
Fact Sheet: SAMHSA 42 CFR Part 2 Revised Rule (CoE-PHI)
Fact sheets to help providers understand the changes to 42 CFR Part 2 and SAMHSA guidance regarding patient privacy.